Alexandra Brouillard

Alexandra Brouillard

Auto-generated profile, based on publicly available information

Alexandra Brouillard

Department of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada; Research Center of the Institut Universitaire en Santé Mentale de Montréal, Montreal, Quebec, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2025 in Psychoneuroendocrinology
Verified
Journal Article
Open access
ABAlexandra Brouillard
Alexandra Brouillard
LDLisa-Marie Davignon
Lisa-Marie Davignon
RCRebecca Cernik
Rebecca Cernik
CGCharles-Édouard Giguère
Charles-Édouard Giguère
HFHelen Findlay
Helen Findlay
MMMarie-France Marin
Marie-France Marin
From a confluence of events, our team acquired salivary sex hormone data from two different assays; namely, enzyme-linked immunosorbent immunoassay (ELISA; Salimetrics) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). As previous research has often discussed inter-assay differences but lacked direct comparative data for these specific hormones in saliva, this paper compared both techniques on their ability to accurately quantify concentrations of estradiol, progesterone, and testosterone in healthy young adults (72 combined oral contraceptive [COC] users, 99 naturally cycling [NC] women in the early follicular and pre-ovulatory phases, and 47 men). Using multivariate and computational approaches, our results converged and showed poor performance of ELISA for measuring salivary sex hormones, with estradiol and progesterone being much less valid than testosterone. Despite its challenges with quantification, LC-MS/MS was found to be superior. Our study underscores the importance of methodological rigor in sex steroid hormone assay techniques, highlighting LC-MS/MS as a more reliable option compared to ELISA for salivary sex hormone quantification in healthy adults. These findings contribute to the ongoing dialogue in the field concerning the validity and reproducibility of scientific discoveries. Indeed, accurate measurement is crucial for generating reliable findings regarding the intricate relationships between hormones, brain, behavior, and mental health.

7 November 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
ABAlexandra Brouillard
Alexandra Brouillard
LDLisa-Marie Davignon
Lisa-Marie Davignon
ATAnne-Marie Turcotte
Anne-Marie Turcotte
MMMarie-France Marin
Marie-France Marin
Background: Endogenous sex hormones and oral contraceptives (OCs) have been shown to influence key regions implicated in fear processing. While OC use has been found to impact brain morphology, methodological challenges remain to be addressed, such as avoiding selection bias between OC users and non-users, as well as examining potential lasting effects of OC intake.Objective: We investigated the current and lasting effects of OC use, as well as the interplay between the current hormonal milieu and history of hormonal contraception use on structural correlates of the fear circuitry. We also examined the role of endogenous and exogenous sex hormones within this network.Methods: We recruited healthy adults aged 23-35 who identified as women currently using (n = 62) or having used (n = 37) solely combined OCs, women who never used any hormonal contraceptives (n = 40), or men (n = 41). Salivary endogenous sex hormones and current users’ salivary ethinyl estradiol (EE) were assessed using liquid chromatography – tandem mass spectrometry. Using structural magnetic resonance imaging, we extracted surface-based gray matter volumes (GMVs) and cortical thickness (CT) for regions of interest of the fear circuitry. Exploratory whole-brain analyses were conducted with surface-based and voxel-based morphometry methods.Results: Compared to men, all three groups of women exhibited a larger GMV of the dorsal anterior cingulate cortex, while only current users showed a thinner ventromedial prefrontal cortex. Irrespective of the menstrual cycle phase, never users exhibited a thicker right anterior insular cortex than past users. While associations with endogenous sex hormones remain unclear, we showed that EE dosage in current users had a greater influence on brain anatomy compared to salivary EE levels and progestin androgenicity, with lower doses being associated with smaller cortical GMVs.Discussion: Our results highlight a sex difference for the dorsal anterior cingulate cortex GMV (a fear-promoting region), as well as a reduced CT of the ventromedial prefrontal cortex (a fear-inhibiting region) specific to current OC use. Precisely, this finding was driven by lower EE doses. These findings may represent structural vulnerabilities to anxiety and stress-related disorders. We showed little evidence of durable anatomical effects, suggesting that OC intake can (reversibly) affect fear-related brain morphology.

8 September 2024 in European Journal of Neuroscience
Verified
Journal Article
Open access
ABAlexandra Brouillard
Alexandra Brouillard
LDLisa‐Marie Davignon
Lisa‐Marie Davignon
ÉVÉtienne Vachon‐Presseau
Étienne Vachon‐Presseau
MRMathieu Roy
Mathieu Roy
MMMarie-France Marin
Marie-France Marin
From adolescence, women become more likely to experience fear dysregulation. Oral contraceptives (OCs) can modulate the brain regions involved in fear processes. OCs are generally used for years and often initiated during adolescence, a sensitive period where certain brain regions involved in the fear circuitry are still undergoing important reorganization. It remains unknown whether OC use during adolescence may induce long‐lasting changes in the fear circuitry. This study aimed to examine whether age of onset moderated the relationship between duration of use and fear‐related brain structures. We collected structural MRI data in 98 healthy adult women (61 current users, 37 past users) and extracted grey matter volumes (GMV) and cortical thickness (CT) of key regions of the fear circuitry. Non‐linear multiple regressions revealed interaction effects between age of onset and quadratic duration of use on GMV of the right hippocampus and right ventromedial prefrontal cortex (vmPFC). Among women who initiated OCs earlier in adolescence, a short duration of use was associated with smaller hippocampal GMV and thicker vmPFC compared to a longer duration of use. For both GMV and CT of the right vmPFC, women with an early OC onset had more grey matter at a short duration of use than those with a later onset. Our results suggest that OC use earlier in adolescence may induce lasting effects on structural correlates of fear learning and its regulation. These findings support further investigation into the timing of OC use to better comprehend how OCs could disrupt normal brain development processes.

15 June 2023 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
LDLisa-Marie Davignon
Lisa-Marie Davignon
ABAlexandra Brouillard
Alexandra Brouillard
MMMarie-France Marin
Marie-France Marin